Steve Jones

Steve Jones, Executive Vice President of Data Driven Business & GenAI at Capgemini, dives into the pressing need for trust and ethical guidelines in AI development. He discusses the shift from experimental AI to its integration in enterprises. Key topics include the evolving skills required for programming in the age of AI, the role of synthetic data in real-time decision-making, and the importance of data governance. Steve highlights how robust frameworks are critical for navigating compliance and aligning AI with organizational goals.

Join Steve Jones, Senior Research Fellow in Genetics, Nicola Foster, Lecturer in Marine Biology, and Gareth Williams, Associate Professor in Marine Biology, as they dive into the fascinating world of corals. They discuss Darwin's revolutionary insights into coral reefs and their slow geological changes. The conversation highlights the alarming threats corals face from climate change and human activity. Topics include the vibrant and intricate ecosystems of coral reefs, their resilience, and even the surprising locations of corals beyond tropical zones.

This week on OM3 Things, Steve Jones and Nekias Duncan discuss their week 2 takeaways. Nekias talks about Scottie Barnes' potential on the Toronto Raptors. Steve discusses the struggles of the Milwaukee Bucks' defense. JJ Redick shares his thoughts on the type of player the Philadelphia 76ers should trade for.

Tune in as Sandra Knapp, a tropical botanist, Nicola Nadeau, an evolutionary biologist, and Steve Jones, a genetics expert, explore the fascinating world of hybrids. They discuss how hybrids can arise naturally or through human intervention, including striking examples like butterflies and orchids. The implications for species classification and biodiversity are profound. They also touch on the alarming decline in wildlife due to environmental factors and the evolving challenges posed by climate change. Discover how hybridization offers new insights for adaptation and survival.

Melvyn Bragg and guests discuss penicillin, discovered by Alexander Fleming in 1928. It is said he noticed some blue-green penicillium mould on an uncovered petri dish at his hospital laboratory, and that this mould had inhibited bacterial growth around it. After further work, Fleming filtered a broth of the mould and called that penicillin, hoping it would be useful as a disinfectant. Howard Florey and Ernst Chain later shared a Nobel Prize in Medicine with Fleming, for their role in developing a way of mass-producing the life-saving drug. Evolutionary theory predicted the risk of resistance from the start and, almost from the beginning of this 'golden age' of antibacterials, scientists have been looking for ways to extend the lifespan of antibiotics.WithLaura Piddock Professor of Microbiology at the University of BirminghamChristoph Tang Professor of Cellular Pathology and Professorial Fellow at Exeter College at the University of OxfordAndSteve Jones Emeritus Professor of Genetics at University College, LondonProducer: Simon Tillotson.